2-Fluoro-4-methylbenzonitrile

We are 2-Fluoro-4-methylbenzonitrile CAS:85070-67-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Fluoro-4-methylbenzonitrile
CAS.NO:85070-67-3
Synonyms:2-fluoro-4-methylbenzenecarbonitrile;
4-methyl-2-fluorobenzonitrile; 
2-fluoro-4-methyl-benzonitrile; 
4-Cyano-3-fluorotoluene;
Molecular Formula:C8H6FN
Molecular Weight:135.13800
 
Physical and Chemical Properties:
Density:1.11;
Melting point:52-53oC;
Boiling point:219.6oC;
Flash point:93.3oC;
Index of Refraction:1.507;
 
Specification:
Appearance:Off-white powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place

2-Fluoro-4-methylbenzonitrile


Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.4519-39-5 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.3-bromo-4-fluorotolueno CAS:452-62-0 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.27311-52-0 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
Ethyl Cyclopropanecarboxylate View Details
3-BROMO-2-FLUORO-4-IODOPYRIDINE View Details
2-Chloro-4,6-dimethoxy-1,3,5-triazine View Details
methyl 2-bromo-2,2-difluoroacetate Cas:683-98-7 manufacturer 1-bromo-4-iodobutane manufacturer 2,6-Dichloro-5-fluoro-3-pyridinecarbonitrile manufacturer 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine manufacturer 1-iodo-4-methylbenzene manufacturer